Fig 3 - by Yunyuan Deng (19556602)

Normalized acinar volumes. by David Haberthür (8407422)

Detailed volume data (in mm³) for each animal. by David Haberthür (8407422)

Delay in first phase viral decay kinetics when ART is started pre-peak. by Brandon F. Keele (7450001)

TIP47 is involved in HCV RNA replication <i>via</i> interaction with NS5A. by Dorothee A. Vogt (247917)

“…Values are expressed as fold increase of luciferase (RLU) per well, over a 4 h time point (mean ± standard deviation; n = 3, *P<0.05, **P<0.01, ***P<0.001). …”

Details of alveolar density (number per mm³) per acinus volume for each animal. by David Haberthür (8407422)

TLC photography of fungal extract. by Shivankar Agrawal (11565095)

Phases of the accumulation of RCVR during primary infection. by Brandon F. Keele (7450001)

The effectiveness of additional rounds of annual 3D-MDA starting in 2023 for three different levels of treatment coverage. by Callum Shaw (15628313)

The effectiveness of the household-based strategy, with different number of teams, treatment radii, and household test aims (HTA). by Callum Shaw (15628313)

Results of ABC fitting—transformed parameters. by Callum Shaw (15628313)

Number of alveoli per acinus volume. by David Haberthür (8407422)

Distribution of the acinar volumes for each animal. by David Haberthür (8407422)

Distribution of the number of alveoli per acinus (entrance ring count per acinus) for each animal. by David Haberthür (8407422)

Statin Effects on Aggression: Results from the UCSD Statin Study, a Randomized Control Trial by Beatrice A. Golomb (140574)

“…</p><p>Trial Registration</p><p>Clinicaltrials.gov <a href="https://clinicaltrials.gov/ct2/show/NCT00330980" target="_blank">NCT00330980</a></p></div>…”

Depletion of xlPTP4A3 inhibits both migration of NCC and uveal melanoma cells. by Selma Maacha (501715)

“…B) Timelapse videomicroscopy of stage 17-derived NCC treated with a pharmacological inhibitor of PTP4A3, a rhodanine derivative (PRL-3 inhibitor I), shows that inhibition of PTP4A3 increases the average of pausing NC cells and strongly decreases the migration velocity of the treated cells (relative to that of vehicle treated cells). …”

Fig 1 - by Khalid Abdul Basit (15332672)

No viral measurement predicts off-ART rebound or not in d3 or d4 ART RMs. by Brandon F. Keele (7450001)

Rebound kinetics and time to detection following ART discontinuation. by Brandon F. Keele (7450001)

Pre- and early post-ART viral dynamics. by Brandon F. Keele (7450001)